# Outdefine

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/outdefine
- **Dataset:** https://optimly.ai/brand/outdefine.json
- **Markdown:** https://optimly.ai/brand/outdefine/llms.txt
- **Official website:** https://outdefine.com
- **Slug:** outdefine
- **Categories:** ai-machine-learning

## Overview

- **Tagline:** Provides governed, auditable, and traceable AI decisions with human-in-the-loop control, specifically designed for regulated life sciences and healthcare environments (SOC 2 Type II, HIPAA, GDPR compliant). It offers continuous learning and scalable deployment without requiring system transformation.
Source: Brand's website (https://outdefine.com) · 2026-10-04

- **Description:** Outdefine provides a governed AI decisioning system for the life sciences sector, unifying fragmented data to enable auditable decisions across clinical trials, R&D, commercial, and manufacturing domains. It features domain-trained reasoning, controlled execution, and traceable evidence with human oversight.
Source: Brand's website (https://outdefine.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - An AI decisioning platform offering applications for clinical trial feasibility
  - patient/site identification
  - real-world data analysis
  - risk monitoring
  - disease landscape mapping
  - unmet need identification
  - portfolio prioritization
  - sales/commercial intelligence
  - market insights
  - manufacturing workflows
  - and operational/supply intelligence.
Source: Brand's website (https://outdefine.com) · 2026-10-04

- **Pricing:** Not specified
Source: Brand's website (https://outdefine.com) · 2026-10-04

## Audience

- **Target industry:** Life sciences organizations, pharmaceutical companies, biotech firms, CROs, and related entities in clinical trials, R&D, commercial operations, and manufacturing that operate in regulated environments.
Source: Brand's website (https://outdefine.com) · 2026-10-04

Page last updated 2026-10-17.